Expired contract

Supply Of Targeted Cell Lineage Separation

Details

Value
GBP 100,000
Duration
3 years
Topic
Biomedical equipment
Published
8 August 2018

Tender description

NHSBT has a requirement for targeted cell lineage separation for use within NHSBT Diagnostic Functions. NHSBT must to be able to perform targeted cell lineage separation: 1) To ensure that NHSBT meet its legal duties and complies with all regulatory and internal quality procedures for diagnostic testing 2) To ensure best value for money Manufacturers will have a proven track record in a similar environment to the Authority and any equipment/ reagents must be validated before by the service before use. All suppliers will be assessed against a standardised set of evaluation criteria prior to the equipment being accepted for use within the service If a company tendering fails to meet an Essential (Must) criteria of this specification then Authority reserves the right to reject the tender without further consideration/ assessment."

Timeline

  1. Completed: Award date23 May 2018
  2. Completed: Award published8 August 2018
    Current notice
  3. Completed: Contract expiry date30 June 2021

About the buyer

NHS Blood and Transplant is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 38434540 · Biomedical equipment

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.